Researchers applied an offline fine-tuned language model and association rule mining to extract critical production factor ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Recent insider activity for Recursion Pharmaceuticals Inc consisted of 1 transaction totaling $18,400.36. The transaction was a Tax Payment by Ben R Taylor, the company’s Chief Financial Officer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results